{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:02:29Z","timestamp":1782853349940,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer New York","isbn-type":[{"value":"9781493971947","type":"print"},{"value":"9781493971961","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7196-1_33","type":"book-chapter","created":{"date-parts":[[2017,8,13]],"date-time":"2017-08-13T14:24:07Z","timestamp":1502634247000},"page":"453-460","source":"Crossref","is-referenced-by-count":29,"title":["Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb)"],"prefix":"10.1007","author":[{"given":"J\u00fcrgen","family":"Patzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"33_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1569070","volume":"42","author":"J Curnow","year":"2016","unstructured":"Curnow J, Pasalic L, Favaloro EJ (2016) Treatment of von Willebrand disease. Semin Thromb Hemost 42:133\u2013146","journal-title":"Semin Thromb Hemost"},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jth.13243","volume":"14","author":"A Jong","year":"2016","unstructured":"Jong A, Eikenboom J (2016) Developments in the diagnostic procedures of von Willebrand disease. J Thromb Hemost 14:449\u2013460","journal-title":"J Thromb Hemost"},{"key":"33_CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","volume":"72","author":"M Bryckaert","year":"2015","unstructured":"Bryckaert M, Rosa JP, Denis CV, Lenting PJ (2015) Of von Willebrand factor and platelets. Cell Mol Life Sci 72:307\u2013326","journal-title":"Cell Mol Life Sci"},{"key":"33_CR4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0034-1376883","volume":"40","author":"P Kn\u00f6bl","year":"2014","unstructured":"Kn\u00f6bl P (2014) Inherited and acquired thrombotic thrombocytopenic Purpura (TTP) in adults. Semin Thromb Hemost 40:493\u2013502","journal-title":"Semin Thromb Hemost"},{"key":"33_CR5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-0034-1376152","volume":"40","author":"WA Hassenpflug","year":"2014","unstructured":"Hassenpflug WA, Budde U, Schneppenheim S, Schneppenheim R (2014) Inherited thrombotic thrombocytopenic purpura in children. Semin Thromb Hemost 40:487\u2013492","journal-title":"Semin Thromb Hemost"},{"key":"33_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","volume":"83","author":"K Vanhoorelbeke","year":"2000","unstructured":"Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H (2000) A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 83:107\u2013113","journal-title":"Thromb Haemost"},{"key":"33_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2002-27818","volume":"28","author":"K Vanhoorelbeke","year":"2002","unstructured":"Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H (2002) A reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. Semin Thromb Hemost 28:161\u2013166","journal-title":"Semin Thromb Hemost"},{"key":"33_CR8","first-page":"77","volume":"89","author":"AB Federici","year":"2004","unstructured":"Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, Ruggeri ZM (2004) A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica 89:77\u201385","journal-title":"Haematologica"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2010-08-299016","volume":"117","author":"VH Flood","year":"2011","unstructured":"Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Hoffmann RG, Montgomery RR (2011) Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman program for the molecular and clinical biology of VWD. Blood 117:67\u201374","journal-title":"Blood"},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/jth.13062","volume":"13","author":"F Stufano","year":"2015","unstructured":"Stufano F, Baronciani L, Pagliari MT, Franchi F, Cozzi G, Garcia-Oya I, Bucciarelli P, Boscarino M, Peyvandi F (2015) Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination. J Thromb Haemost 13:1806\u20131814","journal-title":"J Thromb Haemost"},{"key":"33_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","volume":"20","author":"F Stufano","year":"2013","unstructured":"Stufano F, Lawrie AS, Marca SLA, Berbenni C, Baronciani L, Peyvandi F (2013) A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen. Haemophilia 20:147\u2013153","journal-title":"Haemophilia"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","volume":"20","author":"F Stufano","year":"2014","unstructured":"Stufano F, Lawrie AS, Marca SLA, Berbenni C, Baronciani L, Peyvandi F (2014) A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen. Haemophilia 20:147\u2013153","journal-title":"Haemophilia"},{"key":"33_CR13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.thromres.2015.01.027","volume":"135","author":"A Timm","year":"2015","unstructured":"Timm A, Hillarp A, Philips M, Goetze JP (2015) Comparison of two automated von Willebrand factor activity assays. Thromb Res 135:684\u2013691","journal-title":"Thromb Res"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ijlh.12087","volume":"35","author":"CJ Verfaille","year":"2013","unstructured":"Verfaille CJ, Witte ED, Devreese MJ (2013) Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease. Int J Lab Hematol 35:555\u2013565","journal-title":"Int J Lab Hematol"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/hae.12203","volume":"19","author":"N Cabrera","year":"2013","unstructured":"Cabrera N, Moret A, Caunedo P, Cid AR, Vila V, Espana F, Aznar JA (2013) Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method. Haemophilia 19:920\u2013925","journal-title":"Haemophilia"},{"key":"33_CR16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12380","volume":"20","author":"J Costa-Pinto","year":"2014","unstructured":"Costa-Pinto J, P\u00e9rez-Rodr\u00edguez A, Del M, Gom\u00e9z-del-Castillo C, Lour\u00e9s E, Rodr\u00edguez-Trillo \u00c1, Batlle J, L\u00f3pez-Fern\u00e1ndez MF (2014) Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies. Haemophilia 20:559\u2013567","journal-title":"Haemophilia"},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","volume":"112","author":"E Maistre De","year":"2014","unstructured":"De Maistre E, Volot F, Mourey G, Aho LS, Ternisien C, Briquel ME, Bertrand MA et al (2014) Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance. Thromb Haemost 112:825\u2013830","journal-title":"Thromb Haemost"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.thromres.2015.12.010","volume":"141","author":"EJ Favaloro","year":"2016","unstructured":"Favaloro EJ, Mohammed S (2016) Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease. Thromb Res 141:202\u2013211","journal-title":"Thromb Res"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12064","volume":"19","author":"AS Lawrie","year":"2013","unstructured":"Lawrie AS, Stufano F, Canciani MT, Mackie IJ, Machin SJ, Peyvandi F (2013) A comparative evaluation of a new automated assay for von Willebrand factor activity. Haemophilia 19:338\u2013342","journal-title":"Haemophilia"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","volume":"36","author":"L Graf","year":"2014","unstructured":"Graf L, Moffat KA, Carlino SA, Chan AKC, Iorio A, Giulivi A, Hayward CPM (2014) Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin. Int J Lab Hematol 36:341\u2013351","journal-title":"Int J Lab Hematol"},{"key":"33_CR21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2014.04.033","volume":"134","author":"U Geisen","year":"2014","unstructured":"Geisen U, Zieger B, Nakamura L, Weis A, Heinz J, Michiels JJ, Heilmann C (2014) Comparison of von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo. Thromb Res 134:246\u2013250","journal-title":"Thromb Res"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","volume":"25","author":"J Patzke","year":"2014","unstructured":"Patzke J, Budde U, Huber A, M\u00e9ndez A, Muth H, Obser T, Peerschke E, Wilkens M, Schneppenheim R (2014) Performance evaluation and multicentre study of a von Willebrand factor activity assay base don GPIb binding in the absence of ristocetin. Blood Coagul Fibrinolysis 25:860\u2013870","journal-title":"Blood Coagul Fibrinolysis"},{"key":"33_CR23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","volume":"134","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ, Mohammed S (2014) Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays. Thromb Res 134:1292\u20131300","journal-title":"Thromb Res"},{"key":"33_CR24","unstructured":"CLSI (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline, 5th edn. CLSI document H21-A5. CLSI, Wayne, PA"},{"key":"33_CR25","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","volume":"22","author":"EJ Favaloro","year":"2016","unstructured":"Favaloro EJ, Bonar RA, Mohammed S, Arbelaez A, Niemann J, Freney R, Meiring M et al (2016) Type 2M von Willebrand disease\u00a0\u2013 more often misidentified than correctly identified. Haemophilia 22:e145\u2013e155","journal-title":"Haemophilia"},{"key":"33_CR26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","volume":"134","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ, Bonar RA, Meiring M, Duncan E, Mohammed S, Sioufi J, Marsden K (2014) Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb Res 134:393\u2013403","journal-title":"Thromb Res"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2516.2012.02830.x","volume":"18","author":"PHB Bolton-Maggs","year":"2012","unstructured":"Bolton-Maggs PHB, Favaloro EJ, Hillarp A, Jennings I, Kohler HP (2012) Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders. Haemophilia 18:66\u201372","journal-title":"Haemophilia"},{"key":"33_CR28","first-page":"254","volume":"122","author":"D Lillicrap","year":"2013","unstructured":"Lillicrap D (2013) Von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood 122:254\u2013260","journal-title":"Blood"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/hae.12410","volume":"20","author":"G Castaman","year":"2014","unstructured":"Castaman G, Hillarp A, Goodeve A (2014) Laboratory aspects of von Willebrand disease: test repertoire and options of activity assays and genetic analysis. Haemophilia 20:65\u201370","journal-title":"Haemophilia"},{"key":"33_CR30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/21678707.2015.1066245","volume":"3","author":"EJ Favaloro","year":"2015","unstructured":"Favaloro EJ (2015) Recent advances in laboratory-aided diagnosis of von Willebrand disease. Expert Opin Orphan Drugs 3:975\u2013995","journal-title":"Expert Opin Orphan Drugs"},{"key":"33_CR31","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","volume":"13","author":"I Bod\u00f3","year":"2015","unstructured":"Bod\u00f3 I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J (2015) Platelet dependent von Willebrand factor activity. Nomenclature and methodology: communication from SSC of the ISTH. J Thromb Haemost 13:1345\u20131350","journal-title":"J Thromb Haemost"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0034-1383546","volume":"40","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ (2014) Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Semin Thromb Hemost 40:551\u2013570","journal-title":"Semin Thromb Hemost"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pathol.2016.03.001","volume":"48","author":"EJ Favaloro","year":"2016","unstructured":"Favaloro EJ, Pasalic L, Curnow J (2016) Laboratory tests used to help diagnose von Willebrand disease: an update. Pathology 48:303\u2013318","journal-title":"Pathology"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7196-1_33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T10:46:02Z","timestamp":1570013162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7196-1_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493971947","9781493971961"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_33","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}